News on Medial

AcuraStem Secures $7M in Grant Funding

Finsmes · 1y

AcuraStem, a biotech company based in Pasadena, has received a $7M grant from the National Institutes of Health (NIH) and Department of Defense (DOD). This funding, along with a recent licensing agreement with Takeda valued at $580M, will allow AcuraStem to advance multiple programs towards clinical trials for neurodegenerative diseases. The company's expertise in disease modeling and ASO technology positions them to develop innovative treatments for conditions like sporadic ALS and FTD. Their research is supported by various organizations, including the Alzheimer's Drug Discovery Foundation and Muscular Dystrophy Association.